» Articles » PMID: 17574755

Long-chain Omega-3 Fatty Acid Intake is Associated Positively with Corticolimbic Gray Matter Volume in Healthy Adults

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2007 Jun 19
PMID 17574755
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In animals, dendritic arborization and levels of brain derived neurotrophic factor are positively associated with intake of the omega-3 fatty acids. Here, we test whether omega-3 fatty acid intake in humans varies with individual differences in gray matter volume, an in vivo, systems-level index of neuronal integrity.

Methods: Fifty-five healthy adults completed two 24h dietary recall interviews. Intake of long-chain omega-3 fatty acids was categorized by tertiles. Regional gray matter volumes in a putative emotional brain circuitry comprised of the anterior cingulate cortex (ACC), amygdala and hippocampus were calculated using optimized voxel-based morphometry on high-resolution structural magnetic resonance images.

Results: Region of interest analyses revealed positive associations between reported dietary omega-3 intake and gray matter volume in the subgenual ACC, the right hippocampus and the right amygdala, adjusted for total gray matter volume of brain. Unconstrained whole-brain analyses confirmed that higher intake of omega-3 fatty acids was selectively associated with increased greater gray matter volume in these and not other regions.

Conclusions: Higher reported consumption of the long-chain omega-3 fatty acids is associated with greater gray matter volume in nodes of a corticolimbic circuitry supporting emotional arousal and regulation. Such associations may mediate previously observed effects of omega-3 fatty acids on memory, mood and affect regulation.

Citing Articles

Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review.

Zailani H, Satyanarayanan S, Liao W, Liao H, Huang S, Galecki P J Clin Med. 2023; 12(7).

PMID: 37048736 PMC: 10095486. DOI: 10.3390/jcm12072653.


The Quest for Neurodegenerative Disease Treatment-Focusing on Alzheimer's Disease Personalised Diets.

Palimariciuc M, Balmus I, Gireada B, Ciobica A, Chirita R, Iordache A Curr Issues Mol Biol. 2023; 45(2):1519-1535.

PMID: 36826043 PMC: 9955192. DOI: 10.3390/cimb45020098.


Impact of multidomain preventive strategies on functional brain connectivity in older adults with cognitive complaint: Subset from the Montpellier center of the ancillary MAPT-MRI study.

Perus L, Mangin J, Deverdun J, Gutierrez L, Gourieux E, Fischer C Front Aging Neurosci. 2023; 14:971220.

PMID: 36705622 PMC: 9871772. DOI: 10.3389/fnagi.2022.971220.


Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue.

Heath R, Wood T Int J Mol Sci. 2021; 22(21).

PMID: 34769257 PMC: 8584218. DOI: 10.3390/ijms222111826.


Omega-3 fatty acids are associated with blood-brain barrier integrity in a healthy aging population.

Barnes S, Chowdhury S, Gatto N, Fraser G, Lee G Brain Behav. 2021; 11(8):e2273.

PMID: 34327870 PMC: 8413753. DOI: 10.1002/brb3.2273.